China Includes Cancer Drugs In National Insurance

AI and biological computing tools are optimizing the drug development process, significantly shortening research and development cycles. Consumers should also review SGS test reports to verify product claims. The segment also mentions the sale of Italian olive oil and wine, with a limited quantity remaining for group purchases. It also discusses the importance of checking SGS test reports for specific product claims, such as high concentration of Omega-3 in fish oil. The station also mentions that their annual supply of olive oil and wine from Tuscany, Italy, has sold out, with limited quantities remaining for group purchases. The development is reported as a major step for patient treatment options in China. The development is framed as a new beginning for life and a form of national revitalization. The development follows the successful reporting of four national practical innovation projects. This expansion is described as a shift in the era of medical access. The development follows recent efforts to increase healthcare coverage across the country. Most biological agents and cancer medications listed in China have now entered the national medical insurance catalog. The report was made on Friday, May 5, 2026.